Every Friday you can contact us for a weekly overview in which we briefly look back at the most striking, interesting or most important news items per working day. This week, among other things, the pay rise in care, the father who stabbed his daughter to death, cutbacks in elderly care and the discontinuation of treatment for a woman with esophageal cancer were in the news. In this weekly overview the most important events of this week.
Monday: 1.6 billion of extra money for elderly care has been cut, according to CPB
During an investigation into government measures for care for the elderly, the Central Planning Bureau (CPB) came across cuts that are not included in the coalition agreement. Of the extra 2.7 billion euros that would go to care for the elderly, 1.6 billion euros have been gradually cut back.
Tuesday: wage increase possible with fewer staff
If the hospitals succeed in doing the same work with fewer people, the employees can get the money for which they want to strike at the end of this week. That is what researchers at ABN AMRO say.
Wednesday: father who stabbed six-month-old daughter to death has schizophrenia
The man suspected of stabbing his baby daughter, less than six months old, to death has schizophrenia, according to a psychologist and psychiatrist. That is why he should be sentenced to TBS. Meanwhile, 23-year-old Rotterdammer Ruud S. has confessed to his deed
Thursday: treatment of woman with esophageal cancer in German hospital suddenly stopped
Just before her second chemotherapy treatment at the Helios hospital in Germany, the ill Karen Niessen is told that the treatment will not be reimbursed. In the Netherlands, Niessen, who has esophageal cancer, can no longer be helped. That is why she moved to Krefeld in Germany. According to health insurer ONVZ, it has agreed with the German hospital for a limited number of treatments that it will request permission in advance. And Helios wouldn’t have done that in this case.
Friday: shortage of diabetes drug Ozempic that is circulating on social media as a weight-loss drug
Worldwide there is a shortage of the diabetes medicine Ozempic and this will continue for the rest of the year, writes the Medicines Evaluation Board (MEB). The shortage has arisen because the demand for the drug has increased rapidly. The drug is also used as a weight loss agent and as such is also circulating on social media. It can be dangerous for people with diabetes if they cannot receive Ozempic.
By: National Care Guide